In recent studies, somatic cell gene editing has been performed in vivo by using the CRISPR/Cas9 system transduced via AAV to treat FH induced by the LDLR mutation using germline editing in mouse models.114. This evidence concerns the gene LDLR and familial hyperaldosteronism.